Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
Pharmaceutics
|
March 26, 2022
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
Josefine Schulz, Antonia Thomas, Ayatallah Saleh, et al.
Clinical Pharmacokinetics
|
August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
Franziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
Paediatric Drugs
|
May 16, 2024
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians
Kevin Meesters, Violeta Balbas-Martinez, Karel Allegaert, et al.
Antibiotics (Basel, Switzerland)
|
June 2, 2021
Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure-Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant <i>Escherichia coli</i>
Johanna Seeger, Sebastian Guenther, Katharina Schaufler, et al.
Pharmaceutics
|
April 3, 2021
A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against <i>S. pneumoniae</i> in Mice
Sebastian Franck, Robin Michelet, Fiordiligie Casilag, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 25, 2019
Corrigendum to "Physiologically-Based Pharmacokinetic model for Ciprofloxacin in children with complicated Urinary Tract Infection" [European Journal of Pharmaceutical Sciences 128 (2019) 171-179]
Violeta Balbas-Martinez, Robin Michelet, Andrea N Edginton, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 4, 2018
Physiologically-Based Pharmacokinetic model for Ciprofloxacin in children with complicated Urinary Tract Infection
Violeta Balbas-Martinez, Robin Michelet, Andrea N Edginton, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 9, 2022
A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications
Josefine Schulz, Robin Michelet, Jan F Joseph, et al.
European Journal of Clinical Pharmacology
|
December 4, 2017
Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis
Robin Michelet, Lien Dossche, Charlotte Van Herzeele, et al.
Statistical Methods in Medical Research
|
March 6, 2024
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studies
Sandrine Boulet, Moreno Ursino, Robin Michelet, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
Pharmaceutics
|
March 26, 2022
Towards the Elucidation of the Pharmacokinetics of Voriconazole: A Quantitative Characterization of Its Metabolism
Josefine Schulz, Antonia Thomas, Ayatallah Saleh, et al.
Clinical Pharmacokinetics
|
August 21, 2023
Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data
Franziska Kluwe, Robin Michelet, Wilhelm Huisinga, et al.
Paediatric Drugs
|
May 16, 2024
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians
Kevin Meesters, Violeta Balbas-Martinez, Karel Allegaert, et al.
Antibiotics (Basel, Switzerland)
|
June 2, 2021
Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure-Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant <i>Escherichia coli</i>
Johanna Seeger, Sebastian Guenther, Katharina Schaufler, et al.
Pharmaceutics
|
April 3, 2021
A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against <i>S. pneumoniae</i> in Mice
Sebastian Franck, Robin Michelet, Fiordiligie Casilag, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 25, 2019
Corrigendum to "Physiologically-Based Pharmacokinetic model for Ciprofloxacin in children with complicated Urinary Tract Infection" [European Journal of Pharmaceutical Sciences 128 (2019) 171-179]
Violeta Balbas-Martinez, Robin Michelet, Andrea N Edginton, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 4, 2018
Physiologically-Based Pharmacokinetic model for Ciprofloxacin in children with complicated Urinary Tract Infection
Violeta Balbas-Martinez, Robin Michelet, Andrea N Edginton, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 9, 2022
A versatile high-performance LC-MS/MS assay for the quantification of voriconazole and its N-oxide metabolite in small sample volumes of multiple human matrices for biomedical applications
Josefine Schulz, Robin Michelet, Jan F Joseph, et al.
European Journal of Clinical Pharmacology
|
December 4, 2017
Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis
Robin Michelet, Lien Dossche, Charlotte Van Herzeele, et al.
Statistical Methods in Medical Research
|
March 6, 2024
Bayesian framework for multi-source data integration-Application to human extrapolation from preclinical studies
Sandrine Boulet, Moreno Ursino, Robin Michelet, et al.
Page
of 8